Buprenorphine for Cancer Pain: Results from a Systematic Review
{{output}}
Background: Buprenorphine may be safer and better-tolerated than full mu opioid receptor (MOR) agonists. Whether it effectively controls cancer-related pain is unclear. A prior review (Cochrane 2015) did not support prioritizing ... ...
